US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ImageneBio, Inc.

5.65

-0.0400-0.70%

Post-market: 5.650.00000.00%16:10 EDT

Volume:7K

Turnover:41.12K

Market Cap:63.73M

PE:-1.21

High:5.69

Open:5.69

Low:5.50

Close:5.69

52wk High:18.00

52wk Low:3.94

Shares:11.28M

Float Shares:6.20M

Volume Ratio:0.32

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.6860

EPS(LYR):-9.6449

ROE:-86.15%

ROA:-45.61%

PB:0.52

PE(LYR):-0.59

Loading ...

Overview Company News Filings

Indonesian Exporters Urge Gradual Rollout of Single-Gate Export Policy

ImageneBio CEO presents at Jefferies Global Healthcare Conference

Image Resources NL (ASX:IMA) About To Shift From Loss To Profit

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: ImageneBio (IMA) and Capricor Therapeutics (CAPR)

ImageneBio Price Target Maintained With a $2.00/Share by Wedbush

ImageneBio price target lowered to $24 from $30 at Leerink

ImageneBio Inc reports results for the quarter ended March 31 - Earnings Summary

ImageneBio Q1 EPS $(0.95) Misses $(0.70) Estimate

ImageneBio Q1 FY26 net loss widens to $10.6 million

ImageneBio Inc expected to post a loss of 70 cents a share - Earnings Preview

ImageneBio announces annual shareholder meeting

ImageneBio files Form 3 for Principal Accounting Officer Robert B. Lally

ImageneBio files Form 3 as director Su Wei-guo reports no holdings

Top Midday Gainers

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

ImageneBio prices USD 30 million private placement of pre-funded warrants

Imagenebio Inc - Proceeds to Support Img-007 Development in Alopecia Areata and Atopic Dermatitis

THOMSON REUTERS

Imagenebio Announces $30 Million Private Placement

THOMSON REUTERS

Press Release: ImageneBio Announces $30 Million Private Placement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMA\",,,,,undefined,":{"symbol":"IMA","market":"US","secType":"STK","nameCN":"ImageneBio, Inc.","latestPrice":5.65,"timestamp":1780689600000,"preClose":5.69,"halted":0,"volume":7384,"hourTrading":{"tag":"盘后","latestPrice":5.65,"preClose":5.65,"latestTime":"16:10 EDT","volume":5,"amount":28.25,"timestamp":1780690204069,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0070298769771529055,"floatShares":6199299,"shares":11279100,"eps":-4.686,"marketStatus":"Market Closed","change":-0.04,"latestTime":"06-05 16:00:00 EDT","open":5.69,"high":5.69,"low":5.5,"amount":41120,"amplitude":0.033392,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.686,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":5.69,"preHourTrading":{"tag":"盘前","latestPrice":5.58,"preClose":5.69,"latestTime":"08:13 EDT","volume":87,"amount":481.7004342,"timestamp":1780661586448,"change":-0.11,"changeRate":-0.019332,"amplitude":0.033392},"postHourTrading":{"tag":"盘后","latestPrice":5.65,"preClose":5.65,"latestTime":"16:10 EDT","volume":5,"amount":28.25,"timestamp":1780690204069,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.31964537551589806},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMA\",,,,,undefined,":{"symbol":"IMA","floatShares":6199299,"roa":"-45.61%","roe":"-86.15%","lyrEps":-9.64492,"volumeRatio":0.31964537551589806,"shares":11279100,"dividePrice":0,"high":5.69,"amplitude":0.033392,"preClose":5.69,"low":5.5,"week52Low":3.94,"pbRate":"0.52","week52High":18,"institutionHeld":0,"latestPrice":5.65,"eps":-4.686,"divideRate":0,"volume":7384,"delay":0,"ttmEps":-4.686,"open":5.69,"prevYearClose":6.9,"prevWeekClose":5.88,"prevMonthClose":5.88,"prevQuarterClose":5,"fiveDayClose":5.88,"twentyDayClose":5.91,"sixtyDayClose":6.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-07","symbol":"IMA","fiscalQuarterEnding":"2026/03","expectedEps":-0.7,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.95},{"date":"2026-03-10","symbol":"IMA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773129600000,"name":null,"time":"Pre-Market","dateTimestamp":1773115200000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"IMA","fiscalQuarterEnding":"2025/09","expectedEps":-1.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-2.91},{"market":"US","date":"2025-07-28","symbol":"IMA","defaultRemindTime":1753709400000,"type":"split","dateTimestamp":1753675200000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2025-07-24","symbol":"IMA","fiscalQuarterEnding":"2025/06","expectedEps":-0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753329600000,"reportTimeType":"post","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0,"hold":0,"sell":0,"strongSell":0.3333,"meanLabel":"BUY","meanPercent":0,"analysts":3,"updateTime":1764129600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMA","date":"2026-06-05","current":-1.205719,"percent":0.893204,"low":-8.134224,"twenty":-4.304971,"median":-1.681872,"eighty":-1.425603,"high":-1.122224,"avg":-2.713217,"sd":1.887955,"marketCap":64178249},"quantilePoints":[{"date":"2025-08-15","current":-8.134224,"twenty":-8.112228,"median":-8.06823,"eighty":-8.016532,"marketCap":165376899},{"date":"2025-08-22","current":-7.269609,"twenty":-8.089126,"median":-7.938985,"eighty":-7.265478,"marketCap":157437913},{"date":"2025-08-29","current":-6.949498,"twenty":-8.071529,"median":-7.347055,"eighty":-7.207651,"marketCap":150505278},{"date":"2025-09-05","current":-4.362798,"twenty":-8.06823,"median":-7.269609,"eighty":-7.002161,"marketCap":94485111},{"date":"2025-09-12","current":-4.750028,"twenty":-7.913135,"median":-7.165056,"eighty":-4.777909,"marketCap":102871364},{"date":"2025-09-19","current":-4.311167,"twenty":-7.809737,"median":-7.03727,"eighty":-4.615789,"marketCap":93366944},{"date":"2025-09-26","current":-4.016872,"twenty":-7.532127,"median":-6.908193,"eighty":-4.311167,"marketCap":86993392},{"date":"2025-10-03","current":-4.460896,"twenty":-7.322272,"median":-4.750028,"eighty":-4.238884,"marketCap":96609628},{"date":"2025-10-10","current":-4.24921,"twenty":-7.284065,"median":-4.672583,"eighty":-4.255406,"marketCap":92025144},{"date":"2025-10-17","current":-3.918773,"twenty":-7.257217,"median":-4.460896,"eighty":-4.122198,"marketCap":84868875},{"date":"2025-10-24","current":-3.815512,"twenty":-7.248956,"median":-4.418301,"eighty":-4.002415,"marketCap":82632541},{"date":"2025-10-31","current":-4.336982,"twenty":-7.148276,"median":-4.396358,"eighty":-4.069535,"marketCap":93926028},{"date":"2025-11-07","current":-4.331819,"twenty":-7.057922,"median":-4.378287,"eighty":-4.107742,"marketCap":93814211},{"date":"2025-11-14","current":-4.300841,"twenty":-7.039335,"median":-4.362798,"eighty":-4.109807,"marketCap":93143311},{"date":"2025-11-21","current":-1.760672,"twenty":-6.984607,"median":-4.334401,"eighty":-3.978665,"marketCap":76154335},{"date":"2025-11-28","current":-1.69911,"twenty":-6.937107,"median":-4.311167,"eighty":-3.941491,"marketCap":73491596},{"date":"2025-12-05","current":-1.66956,"twenty":-6.910259,"median":-4.306004,"eighty":-3.874371,"marketCap":72213481},{"date":"2025-12-12","current":-1.593223,"twenty":-6.057319,"median":-4.275025,"eighty":-1.94191,"marketCap":68911685},{"date":"2025-12-19","current":-1.524274,"twenty":-4.777909,"median":-4.254373,"eighty":-1.770522,"marketCap":65929417},{"date":"2025-12-26","current":-1.44055,"twenty":-4.748995,"median":-4.244047,"eighty":-1.699602,"marketCap":62308092},{"date":"2026-01-02","current":-1.69911,"twenty":-4.744865,"median":-4.207906,"eighty":-1.69911,"marketCap":73491596},{"date":"2026-01-09","current":-1.686797,"twenty":-4.71905,"median":-4.130459,"eighty":-1.664635,"marketCap":72959048},{"date":"2026-01-16","current":-1.62031,"twenty":-4.626115,"median":-4.109807,"eighty":-1.664635,"marketCap":70083290},{"date":"2026-01-23","current":-1.740972,"twenty":-4.605462,"median":-4.016872,"eighty":-1.646413,"marketCap":75302258},{"date":"2026-01-30","current":-1.803765,"twenty":-4.550733,"median":-3.972986,"eighty":-1.66168,"marketCap":78018252},{"date":"2026-02-06","current":-1.726197,"twenty":-4.505299,"median":-3.939426,"eighty":-1.666605,"marketCap":74663201},{"date":"2026-02-13","current":-1.686797,"twenty":-4.492908,"median":-3.903284,"eighty":-1.667098,"marketCap":72959048},{"date":"2026-02-20","current":-1.64986,"twenty":-4.473288,"median":-3.838746,"eighty":-1.658725,"marketCap":71361405},{"date":"2026-02-27","current":-1.681872,"twenty":-4.451603,"median":-2.010613,"eighty":-1.64986,"marketCap":72746029},{"date":"2026-03-06","current":-1.487337,"twenty":-4.445407,"median":-1.864096,"eighty":-1.631638,"marketCap":64331774},{"date":"2026-03-13","current":-1.479416,"twenty":-4.442309,"median":-1.812384,"eighty":-1.610461,"marketCap":67090032},{"date":"2026-03-20","current":-1.403396,"twenty":-4.424754,"median":-1.804381,"eighty":-1.602088,"marketCap":63642621},{"date":"2026-03-27","current":-1.33187,"twenty":-4.403586,"median":-1.785297,"eighty":-1.581403,"marketCap":60398973},{"date":"2026-04-02","current":-1.245545,"twenty":-4.395325,"median":-1.760672,"eighty":-1.558256,"marketCap":56484224},{"date":"2026-04-10","current":-1.171552,"twenty":-4.381385,"median":-1.750822,"eighty":-1.52919,"marketCap":53128726},{"date":"2026-04-17","current":-1.425594,"twenty":-4.352472,"median":-1.745897,"eighty":-1.516394,"marketCap":64649271},{"date":"2026-04-24","current":-1.445326,"twenty":-4.336982,"median":-1.731122,"eighty":-1.485808,"marketCap":65544070},{"date":"2026-05-01","current":-1.484788,"twenty":-4.334917,"median":-1.726197,"eighty":-1.480666,"marketCap":67333669},{"date":"2026-05-08","current":-1.457658,"twenty":-4.323558,"median":-1.705266,"eighty":-1.466579,"marketCap":66103320},{"date":"2026-05-15","current":-1.336106,"twenty":-4.311167,"median":-1.701572,"eighty":-1.456178,"marketCap":66659658},{"date":"2026-05-22","current":-1.247936,"twenty":-4.311167,"median":-1.69911,"eighty":-1.439072,"marketCap":62260797},{"date":"2026-05-29","current":-1.339497,"twenty":-4.310134,"median":-1.692954,"eighty":-1.43694,"marketCap":66828845},{"date":"2026-06-05","current":-1.286369,"twenty":-4.304971,"median":-1.681872,"eighty":-1.425603,"marketCap":64178249}],"updateTime":1780885387162},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640093128","title":"Indonesian Exporters Urge Gradual Rollout of Single-Gate Export Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2640093128","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640093128?lang=en_us&edition=fundamental","pubTime":"2026-06-01 12:32","pubTimestamp":1780288338,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Indonesian business groups have called on the government to pay close attention to the implementation of the country’s new single-gate export policy, which took effect on Monday th","market":"sh","thumbnail":"https://statik.tempo.co/data/2023/01/31/id_1177617/1177617_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2023/01/31/id_1177617/1177617_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2106226/indonesian-exporters-urge-gradual-rollout-of-single-gate-export-policy","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2106226/indonesian-exporters-urge-gradual-rollout-of-single-gate-export-policy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4588","IMA","BK4007","IMA.AU","DMO","BK4585","BK7095","DSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638636936","title":"ImageneBio CEO presents at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638636936","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638636936?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:31","pubTimestamp":1779913876,"startTime":"0","endTime":"0","summary":"ImageneBio will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026 at 12:50 PM EDT.Management will also hold one-on-one meetings with investors during the conference.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL1NSXjB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014013.SGD","SG9999014039.USD","SG9999014005.SGD","IE00BN0W2W23.USD","SG9999014021.USD","IMA","BK4007","LU2210149790.SGD","IE00BKPKM429.USD","BK4585","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","LU0314104364.USD","NDAQ","LU2210150020.SGD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637347300","title":"Image Resources NL (ASX:IMA) About To Shift From Loss To Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2637347300","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637347300?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:37","pubTimestamp":1779482255,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Image Resources NL's ( ASX:IMA ) business as it appears the company may be...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ima/image-resources-shares/news/image-resources-nl-asxima-about-to-shift-from-loss-to-profit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ima/image-resources-shares/news/image-resources-nl-asxima-about-to-shift-from-loss-to-profit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NL","IMA.AU","BK4007","BK4143","BK7095","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634128748","title":"Analysts Offer Insights on Healthcare Companies: ImageneBio (IMA) and Capricor Therapeutics (CAPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634128748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634128748?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:00","pubTimestamp":1778508031,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on ImageneBio (IMA) and Capricor Therapeutics (CAPR). ImageneBio (IM...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-imagenebio-ima-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-imagenebio-ima-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","HCSG","BK4581","BK4139","BK4007","LABU","XBI","BK4585","IMA","BK4588","CAPR","LU0029874061.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634728166","title":"ImageneBio Price Target Maintained With a $2.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2634728166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634728166?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:42","pubTimestamp":1778503320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 08:42 ET (12:42 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633645432","title":"ImageneBio price target lowered to $24 from $30 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2633645432","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633645432?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:12","pubTimestamp":1778235172,"startTime":"0","endTime":"0","summary":"Leerink analyst David Risinger lowered the firm’s price target on ImageneBio (IMA) to $24 from $30 and keeps an Outperform rating on the shares. Pu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/imagenebio-price-target-lowered-to-24-from-30-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/imagenebio-price-target-lowered-to-24-from-30-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633103460","title":"ImageneBio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633103460","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633103460?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:26","pubTimestamp":1778192778,"startTime":"0","endTime":"0","summary":"ImageneBio Inc reports results for the quarter ended March 31 - Earnings SummaryImageneBio Inc IMA.OQ reported a quarterly adjusted loss of 95 cents per share for the quarter ended March 31, higher th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K3JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633172496","title":"ImageneBio Q1 EPS $(0.95) Misses $(0.70) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633172496","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633172496?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:44","pubTimestamp":1778186690,"startTime":"0","endTime":"0","summary":"ImageneBio (NASDAQ:IMA) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.70) by 35.71 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52393051/imagenebio-q1-eps-0-95-misses-0-70-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","FTEC","NQmain","QQQE","SQQQ","MNQmain","QLD","IYW","PSQ","QQQJ","NVIW.SI","TQQY","JEPQ","QID","QQQ","QQQA","QQQM","QQQY","IMA","ONEQ","BK4007","GPIQ","NDX","QYLG","QDTE",".IXIC","TECS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633748981","title":"ImageneBio Q1 FY26 net loss widens to $10.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633748981","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633748981?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:24","pubTimestamp":1778185484,"startTime":"0","endTime":"0","summary":"ImageneBio posted a net loss of $10.6 million for the quarter ended March 31, 2026, widening from $9.1 million a year earlier.R&D expense rose to $6 million from $4 million, while G&A expense climbed to $6.1 million from $2.8 million.Cash, cash equivalents, and marketable securities totaled $117.2 million at quarter-end; an April private placement raised about $30 million in gross proceeds, extending cash runway into Q1 2028.Phase 2b ADAPTIVE trial of lead candidate IMG-007 in atopic dermatitis is progressing under an amended protocol, with topline data expected in Q4 2027.Plans call for initiating a Phase 2 alopecia areata study in 2026 with initial data expected in 2028, following open-label proof-of-concept results showing a mean SALT 30 improvement of 30% at 36 weeks after three 600 mg IV doses in the first month.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL2QSml6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2210149790.SGD","SG9999014013.SGD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","BK4007","IE00BN0W2V16.EUR","LU0314104364.USD","IMA","BK4112","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00B64PRP62.GBP","SG9999014005.SGD","NDAQ","BK4588","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632956300","title":"ImageneBio Inc  expected to post a loss of 70 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632956300","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632956300?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:24","pubTimestamp":1777901057,"startTime":"0","endTime":"0","summary":"ImageneBio Inc  expected to post a loss of70cents a share - Earnings Preview ImageneBio Inc IMA.OQ IMA.O is expected to  show no change in quarterly revenue when it reports  results on May 6 (estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H1AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632664582","title":"ImageneBio announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2632664582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632664582?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:06","pubTimestamp":1777583173,"startTime":"0","endTime":"0","summary":"ImageneBio scheduled virtual annual stockholders meeting for June 16, 2026.Shareholders will vote to elect two Class II director nominees to terms running to 2029 annual meeting.Approval sought for amended and restated 2025 Equity Incentive Plan, including 850,000-share increase in authorized issuance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImageneBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL62fp1G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629771636","title":"ImageneBio files Form 3 for Principal Accounting Officer Robert B. Lally","url":"https://stock-news.laohu8.com/highlight/detail?id=2629771636","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629771636?lang=en_us&edition=fundamental","pubTime":"2026-04-21 05:44","pubTimestamp":1776721448,"startTime":"0","endTime":"0","summary":"ImageneBio Principal Accounting Officer Robert B. Lally filed an initial beneficial ownership statement reporting 58,778 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImageneBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL7VtvZv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628240563","title":"ImageneBio files Form 3 as director Su Wei-guo reports no holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2628240563","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628240563?lang=en_us&edition=fundamental","pubTime":"2026-04-17 07:55","pubTimestamp":1776383756,"startTime":"0","endTime":"0","summary":"ImageneBio filed an initial Form 3 naming Su Wei-guo as a director on April 16, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImageneBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL8t43DN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627145026","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2627145026","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627145026?lang=en_us&edition=fundamental","pubTime":"2026-04-14 02:19","pubTimestamp":1776104350,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics  shares soared 29% after the company said Monday its SPY001 investigational treatment for moderate-to-severely active ulcerative colitis met its key targets in a phase 2 trial.Over 4.10 million shares traded intraday, versus a daily average of roughly 747,000.ImageneBio  reported Monday that its private placement with certain institutional investors is expected to result in gross proceeds of about $30 million to the company.Shares jumped 22%, with intraday trading volume catapulting to more than 17.5 million from a daily average of about 38,000.Price: 65.06, Change: +13.77, Percent Change: +26.85","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMA","BK4007","BK4139","IMA.AU","BK7095","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627450630","title":"BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune","url":"https://stock-news.laohu8.com/highlight/detail?id=2627450630","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627450630?lang=en_us&edition=fundamental","pubTime":"2026-04-14 01:50","pubTimestamp":1776102619,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, ReplimuneWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL6N40W0LU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APTV","GOOGL","CAG","BIIB","LYB","MARA","CRM","OCUL","ORCL","BBY","IDYA","SBUX","DOW","XOM","HP","CDE","OXY","APP","COIN","PINS","DVN","SYRE","RVMD","DAL","NEM","RIOT","GPRO","ALLO","IBM","TFX","GFL","DIOD","LEG","ADBE","META","LUV","HL","HPE","REPL","UAL","HUT","ANIP","SNDK","KYMR","AVT","EMN","NOW","CVX","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627144454","title":"BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627144454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627144454?lang=en_us&edition=fundamental","pubTime":"2026-04-13 23:43","pubTimestamp":1776095026,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-SonomaWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL6N40W0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRWV","CDE","EMN","SYRE","LYB","WSM","IBM","BIIB","ADBE","DOW","MARA","RIOT","GPRO","APTV","IMA","ANIP","BBY","TFX","META","DAL","NEM","OCUL","AAL","OXY","DVN","DIOD","XOM","HTFL","IDYA","RVMD","REPL","SNDK","CAG","OWL","AVT","LEG","COIN","UAL","HPE","CVX","HL","GOOGL","ALLO","SBUX","HUT","LUV","PINS","SBU","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432152","title":"ImageneBio prices USD 30 million private placement of pre-funded warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432152","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432152?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:03","pubTimestamp":1776078217,"startTime":"0","endTime":"0","summary":"ImageneBio entered securities purchase agreement for private placement expected to raise about USD 30 million in gross proceeds.Offering consists of pre-funded warrants to buy up to 5,770,335 common shares priced at USD 5.2 each.Warrants carry exercise price of USD 0.001 per share.Proceeds earmarked for development of IMG-007 in alopecia areata, late-stage work in atopic dermatitis.Placement led by Coastlands Capital; Leerink Partners acting as sole placement agent.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL74t8qV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014005.SGD","LU0314104364.USD","BK4112","BK4588","BK4007","LU2095319765.USD","NDAQ","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","MNSH","IMA","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BN0W2W23.USD","BK4207","IE00BKPKM429.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","LU2210150020.SGD","BK4585","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432960","title":"Imagenebio Inc - Proceeds to Support Img-007 Development in Alopecia Areata and Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432960?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA8Z60LM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432675","title":"Imagenebio Announces $30 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432675?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA8Z60LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432926","title":"Press Release: ImageneBio Announces $30 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432926","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432926?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078000,"startTime":"0","endTime":"0","summary":"Private placement led by Coastlands Capital with participation. SAN DIEGO, April 13, 2026  -- ImageneBio, Inc.  today announced it has entered into a definitive securities purchase agreement with certain institutional investors in a private placement that is expected to result in gross proceeds of approximately $30 million to Imagene, before deducting placement agent fees and other expenses. The company intends to use the proceeds from the offering to support further development of IMG-007 in alopecia areata and late-stage development activities in atopic dermatitis.Pursuant to the terms of the securities purchase agreement, Imagene is selling pre-funded warrants to purchase up to 5,770,335 shares of common stock at a price of $5.199 per pre-funded warrant. The pre-funded warrants will have an exercise price of $0.001 per share.Leerink Partners is acting as sole placement agent for the private placement.The securities offered in this private placement, including the shares underlying t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}